Forecast Newsletter

Spring HIV/ARV Update brings latest in HIV research to Vancouver from local and international speakers

By

The spring HIV/ARV Update brought expert presentations about scientific findings on hepatitis B and HIV co-infection, breastfeeding policies, HIV cure strategies, and more. China’s chief epidemiologist addresses the country’s HIV epidemic Dr. Zunyou Wu—Chief Epidemiologist, China Centre for Disease Control and Prevention (China CDC), and Director of Division of HIV Prevention, the National Centre for […]

Spring HIV/ARV Update brings latest in HIV research to Vancouver from local and international speakers Read More »

Made-in-BC Treatment as Prevention strategy recognized locally, nationally and globally

By

On April 24th, Federal Health Minister Hon. Ginette Petitpas Taylor visited the BC Centre for Excellence in HIV/AIDS (BC-CfE) to speak to Executive Director & Physician-in-Chief Dr. Julio Montaner about BC’s leadership in HIV, hepatitis C (HCV) and opioid use disorder (OUD). The BC-CfE has long played an essential role in the testing, diagnosis, treatment

Made-in-BC Treatment as Prevention strategy recognized locally, nationally and globally Read More »

BC-CfE announces provincewide initiative to increase access to lifesaving treatment for opioid use disorder

By

On January 17th, the BC-CfE announced the launch of a provincewide initiative, supported by a funding grant from Health Canada’s Substance Use and Addiction Program. The first-of-its-kind initiative based on the BC-CfE’s world-renowned Treatment as Prevention (TasP) strategy to curb HIV and AIDS—will roll out across all BC regional health authorities in early 2019. This

BC-CfE announces provincewide initiative to increase access to lifesaving treatment for opioid use disorder Read More »

China CDC and BC-CfE renewed partnership reaffirms commitment to fight HIV

By

China is facing an HIV epidemic that is on the scale of its population of approximately 1.4 billion. The BC-CfE is providing valuable insights on successful tactics, programs and strategies implemented in British Columbia to curb HIV. Namely, the BC-CfE’s Treatment as Prevention (TasP) strategy has transformed the province from the one with the highest

China CDC and BC-CfE renewed partnership reaffirms commitment to fight HIV Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search